The influence of Simvastatin carried by Chitosan nanoparticle on bone regeneration using Masson’s Trichrome histochemical stain
Main Article Content
Abstract
Background: Due to the complicated and time-consuming physiological procedure of bone healing, certain graft materials have been frequently used to enhance the reconstruction of the normal bone architecture. However, owing to the limitations of these graft materials, some pharmaceutical alternatives are considered instead. Chitosan is a biopolymer with many distinguishing characteristics that make it one of the best materials to be used as a drug delivery system for simvastatin. Simvastatin is a cholesterol lowering drug, and an influencer in bone formation process, because it stimulates osteoblasts differentiation, bone morphogenic protein 2, and vascular endothelial growth factor. Objectives: histological, histochemical and histomorphometrical analyses were carried out to evaluate the effect of local application of chitosan simvastatin nanoparticles (ChSimN) on bone healing. Materials and Methods: New Zealand rabbits (n=14) were used in this study. Two defects were made: one on the right side (the experimental side) that received ChSimN and the other one on the left side (the control side), which left to heal spontaneously. Seven rabbits were sacrificed after 2 weeks of the experiments, while the others after 4 weeks. Bone samples were taken for histological and histomorphometric study after the sacrifice. Results: The histological study, using both H&E and Masson’s Trichrome stain, revealed that the ChSimN group recorded an increased amount of bone formation at both time points. Histomorphometrical analysis recorded a significant increment in bone marrow and trabecular areas in the ChSimN group. Conclusion: ChSimN had a pronounced effect on bone formation.
Received date: 02-08-2023
Accepted date: 10-10-2023
Published date: 15-12-2023
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licenses and Copyright
The following policy applies in The Journal of Baghdad College of Dentistry (JBCD):
# JBCD applies the Creative Commons Attribution (CC BY) license to articles and other works we publish. If you submit your paper for publication by JBCD, you agree to have the CC BY license applied to your work. Under this Open Access license, you as the author agree that anyone can reuse your article in whole or part for any purpose, for free, even for commercial purposes. Anyone may copy, distribute, or reuse the content as long as the author and original source are properly cited. This facilitates freedom in re-use and also ensures that JBCD content can be mined without barriers for the needs of research.
# If your manuscript contains content such as photos, images, figures, tables, audio files, videos, etc., that you or your co-authors do not own, we will require you to provide us with proof that the owner of that content (a) has given you written permission to use it, and (b) has approved of the CC BY license being applied to their content. We provide a form you can use to ask for and obtain permission from the owner. If you do not have owner permission, we will ask you to remove that content and/or replace it with other content that you own or have such permission to use.Don't assume that you can use any content you find on the Internet, or that the content is fair game just because it isn't clear who the owner is or what license applies.
# Many authors assume that if they previously published a paper through another publisher, they own the rights to that content and they can freely use that content in their paper, but that’s not necessarily the case, it depends on the license that covers the other paper. Some publishers allow free and unrestricted re-use of article content they own, such as under the CC BY license. Other publishers use licenses that allow re-use only if the same license is applied by the person or publisher re-using the content. If the paper was published under a CC BY license or another license that allows free and unrestricted use, you may use the content in your JBCD paper provided that you give proper attribution, as explained above.If the content was published under a more restrictive license, you must ascertain what rights you have under that license. At a minimum, review the license to make sure you can use the content. Contact that JBCD if you have any questions about the license. If the license does not permit you to use the content in a paper that will be covered by an unrestricted license, you must obtain written permission from the publisher to use the content in your JBCD paper. Please do not include any content in your JBCD paper which you do not have rights to use, and always give proper attribution.
# If any relevant accompanying data is submitted to repositories with stated licensing policies, the policies should not be more restrictive than CC BY.
# JBCD reserves the right to remove any photos, captures, images, figures, tables, illustrations, audio and video files, and the like, from any paper, whether before or after publication, if we have reason to believe that the content was included in your paper without permission from the owner of the content.
How to Cite
Publication Dates
References
Jiang F, Yin F, Lin Y, Xia W, Zhou L, Pan C, et al. The promotion of bone regeneration through CS/GP-CTH/antagomir-133a/b sustained release system. Nanomedicine. 2020; 24, 102116. DOI: https://doi.org/10.1016/j.nano.2019.102116
Jafernik K, Ładniak A, Blicharska E, Czarnek K, Ekiert H, Wiącek AE, et al. Chitosan-Based Nanoparticles as Effective Drug Delivery Systems-A review. Molecules. 2023; 28. DOI: https://doi.org/10.3390/molecules28041963
Elkomy MH, Ali AA, Eid HM. Chitosan on the surface of nanoparticles for enhanced drug delivery: A comprehensive review. J Control Release. 2022; 351, 923-940. DOI: https://doi.org/10.1016/j.jconrel.2022.10.005
Mohammed HJ, Zaidan, TF. Taste Detection Thresholds in Relation to Salivary and Serum Zinc in Patients on Simvastatin Treatment. J Bagh Coll Dent. 2019; 31, 25-31. DOI: https://doi.org/10.26477/jbcd.v31i2.2620
Garrett IR, Gutierrez G, Mundy GR. Statins and bone formation. Curr Pharm Des. 2001; 7, 715-736. DOI: https://doi.org/10.2174/1381612013397762
Papadimitriou K, Karkavelas G, Vouros I, Kessopoulou E, Konstantinidis A. Effects of local application of simvastatin on bone regeneration in femoral bone defects in rabbit. J Craniomaxillofac Surg. 2015; 43, 232-237. DOI: https://doi.org/10.1016/j.jcms.2014.11.011
Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, et al. Stimulation of bone formation in vitro and in rodents by statins. Science. 1999; 286, 1946-1949. DOI: https://doi.org/10.1126/science.286.5446.1946
Delan W, Elsaadany B, Fares A, ElMeshad A, Mamdouh W, Zakaria M. Histomorphometric analysis of bone formation after using simvastatin chitosan nanoparticles as a local delivery system in periodontal bony defects in rabbits. ADJC. 2021; 3, 109-119. DOI: https://doi.org/10.21608/adjc.2021.74327.1097
Mohamed IF, Ghani BA, Fatalla AA. Histological Evaluation of the Effect of Local Application of Punica granatum Seed Oil on Bone Healing. Int J Biomater. 2022; 4266589. DOI: https://doi.org/10.1155/2022/4266589
AL-Ghaban NM., Jasem GH. Histomorphometric evaluation of the effects of local application of red cloveroil (trifolium pratense) on bone healing in rats. J Bagh Coll Dent. 2020; 32, 26-31. DOI: https://doi.org/10.26477/jbcd.v32i2.2891
Fadhil E, Dosh RH, Wally ZJ, Haider J. Histological evaluation of the effects of bone morphogenetic protein 9 and angiopoietin 1 on bone healing. J Taibah Univ Med Sci. 2023; 18, 954-963. DOI: https://doi.org/10.1016/j.jtumed.2023.02.005
Collins TJ. ImageJ for microscopy. Bio Techniques. 2007; 43, S25-S30. DOI: https://doi.org/10.2144/000112517
Amini AR, Laurencin CT, Nukavarapu SP. Bone tissue engineering: recent advances and challenges. Crit Rev Biomed Eng. 2012; 40, 363-408. DOI: https://doi.org/10.1615/CritRevBiomedEng.v40.i5.10
BaoLin G, Ma PX. Synthetic biodegradable functional polymers for tissue engineering: a brief review. Sci China Chem. 2014; 57, 490-500. DOI: https://doi.org/10.1007/s11426-014-5086-y
Langer R, Vacanti JP. Tissue engineering. Science. 1993; 260, 920-926. DOI: https://doi.org/10.1126/science.8493529
Liu M, Zhang Y, Wu C, Xiong S, Zhou C. Chitosan/halloysite nanotubes bionanocomposites: Structure, mechanical properties and biocompatibility. Int J Biol Macromol. 2012; 51, 566-575. DOI: https://doi.org/10.1016/j.ijbiomac.2012.06.022
Ghadri N, Anderson KM, Adatrow P, Stein SH, Su H, Garcia-Godoy F,et al. Evaluation of bone regeneration of simvastatin loaded chitosan nanofiber membranes in rodent calvarial defects. jbnb. 2018; 9, 210. DOI: https://doi.org/10.4236/jbnb.2018.92012
Yamashita M, Otsuka F, Mukai T, Otani H, Inagaki K, Miyoshi T, et al. Simvastatin antagonizes tumor necrosis factor-α inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway. J Endocrinol. 2008; 196, 601-613. DOI: https://doi.org/10.1677/JOE-07-0532
Stübinger S, Dard M. The rabbit as experimental model for research in implant dentistry and related tissue regeneration. J Invest Surg. 2013; 26, 266-282. DOI: https://doi.org/10.3109/08941939.2013.778922
Lundgren A, Sennerby L, Lundgren D. An experimental rabbit model for jaw-bone healing. Int J Oral Maxillofac Surg. 1997; 26, 461-464. DOI: https://doi.org/10.1016/S0901-5027(97)80015-X
Delan WK, Zakaria M, Elsaadany B, ElMeshad AN, Mamdouh W, Fares AR. Formulation of simvastatin chitosan nanoparticles for controlled delivery in bone regeneration: Optimization using Box-Behnken design, stability and in vivo study. Int J Pharm. 2020; 577, 119038. DOI: https://doi.org/10.1016/j.ijpharm.2020.119038
Xue Y, Wu M, Liu Z, Song J, Luo S, Li H, et al. In vitro and in vivo evaluation of chitosan scaffolds combined with simvastatin-loaded nanoparticles for guided bone regeneration. J Mater Sci Mater Med. 2019; 30, 47. DOI: https://doi.org/10.1007/s10856-019-6249-3
AL-Mashhadi ZAJ, AL-Ghaban NM. Local Evaluation of Chitosan and β-Tricalcium Phosphate alone and Combination in Bone Defect of Rabbit by Histological and Histomorphometric Analysis. J Res Med Dent Sci. 2022; 10, 171-178.
Oryan A, Sahvieh S. Effectiveness of chitosan scaffold in skin, bone and cartilage healing. Int J Biol Macromol. 2017; 104, 1003-1011. DOI: https://doi.org/10.1016/j.ijbiomac.2017.06.124
Amal I, Soebroto H, Puruhito. Comparison of bone wax and chitosan usage on post-sternotomy bone healing. Asian Cardiovasc Thorac Ann. 2021; 29, 203-207. DOI: https://doi.org/10.1177/0218492320984097
Diniz JA, Barbirato DDS, do Nascimento EHL, Pontual ADA, Dourado ACAG, Laureano Filho JR. Tomographic evaluation of the effect of simvastatin topical use on alveolar bone microarchitecture, pain and swelling after mandibular third molar extraction: a randomized controlled trial. Clin Oral Investig. 2022; 26, 3533-3545. DOI: https://doi.org/10.1007/s00784-021-04322-8
Moshiri A, Sharifi AM, Oryan A. Role of Simvastatin on fracture healing and osteoporosis: a systematic review on in vivo investigations. Clin Exp Pharmacol Physiol. 2016; 43, 659-684. DOI: https://doi.org/10.1111/1440-1681.12577
Murtaza G. Solubility enhancement of simvastatin: a review. Acta Pol Pharm 2012, 69, 581-590.
Lee JY, Nam SH, Im SY, Park YJ, Lee YM, Seol YJ, et al. Enhanced bone formation by controlled growth factor delivery from chitosan-based biomaterials. J Control Release. 2002; 78, 187-197. DOI: https://doi.org/10.1016/S0168-3659(01)00498-9
Sakoda K., Yamamoto M, Negishi Y, Liao J, Node K, Izumi Y. Simvastatin decreases IL-6 and IL-8 production in epithelial cells. J Dent Res. 2006; 85, 520-523. DOI: https://doi.org/10.1177/154405910608500608